Skip to content

Imaging deep target engagement of transcranial ultrasonic stimulation

Imaging deep target engagement of transcranial ultrasonic stimulation - Deep brain transcranial ultrasonic stimulation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON53361
Enrollment
45
Registered
2023-03-30
Start date
2023-05-15
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

normal brain function normal brain function

Interventions

Participants receive TUS targeting the amygdala/mediodorsal thalamus/pulvinar thalamus.

Sponsors

Radboud Universiteit Nijmegen
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Between 18-40 years of age; - The ability and agreement to provide informed consent in sound body and mind, and the ability to fulfil the study*s requirements.

Exclusion criteria

Exclusion criteria: • Under 18 years of age; • Current pregnancy; • Claustrophobia; • A history or brain surgery or serious head trauma; • A history of or any close relatives (parents, siblings, children) with epilepsy, convulsion, or seizure; • Predisposition for fainting spells (syncope); • A cardiac pacemaker or intra-cardiac lines; • An implanted neurostimulator; • Implanted medication infusion device; • Implanted metal devices or large ferromagnetic fragments in the head or upper body (excluding dental wire), or jewellery/piercing that cannot be removed; • Use of a medical plaster that cannot or may not be taken off (e.g., nicotine plaster); • Cochlear implants; • Metal in the brain, skull, or elsewhere in your body (fragments, clips, etc.); • Diagnosed neurological or psychiatric disorders; • Use of psychoactive (prescription) medication (excluding anti-conception); • Skin disease at intended stimulation sites; • The consumption of more than four alcoholic units within 24 hours before participation • The consumption of recreational drugs within 48 hours before participation; • Calcifications in the brain. • All other criteria relevant to non-invasive brain stimulation as reported in the Donders Standard Operating Procedures for Non-Invasive Brain Stimulation.

Design outcomes

Primary

MeasureTime frame
Intrinsic functional connectivity profiles and task sensitivity of the target regions (amygdala, mediodorsal thalamus, pulvinar thalamus) are the primary dependent measures that will be used to assess TUS target engagement.

Secondary

MeasureTime frame
We will test the activation of the mediodorsal thalamus and pulvinar thalamus when a flexible processing task engages these regions.

Countries

Netherlands

Contacts

Public ContactCE Evans

Radboud Universiteit Nijmegen

carys.evans@donders.ru.nl0625771510

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 20, 2026